Clinical Trial Update: Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluating twice-daily LEO 124249 ointment for chronic hand eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• LEO 124249 ointment

Snippet

Sponsor: LEO Pharma | Conditions: Hand Eczema | Phase 2 | Status: COMPLETED